Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Gastroenterology

GI Infectious Disease

Efficacy of preoperative oral antibiotic prophylaxis for the prevention of surgical site infections in patients with Crohn disease: A randomized controlled trial

Annals of Surgery | Feb 13, 2019 GI Infectious Disease

Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma

Liver International | Feb 10, 2019 GI Infectious Disease

A retrospective study of the efficacy of sofosbuvir plus NS5A inhibitors for patients with hepatitis C virus genotype-2 chronic infection

European Journal of Gastroenterology & Hepatology | Feb 08, 2019 GI Infectious Disease

Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: A collaboration of cohort studies

The Lancet HIV | Feb 08, 2019 GI Infectious Disease

Sofosbuvir in combination with ribavirin or simeprevir: Real-life study of patients with hepatitis C genotype 4

Annals of Gastroenterology | Feb 08, 2019 GI Infectious Disease

Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection

Liver International | Feb 07, 2019 GI Infectious Disease

Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM vs alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma

Clinical and Experimental Gastroenterology | Feb 07, 2019 GI Infectious Disease

Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): An open-label, multicentre, single-arm, phase 3b trial

The Lancet: Gastroenterology & Hepatology | Feb 06, 2019 GI Infectious Disease

Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: A systematic review and pooled meta-analyses

The Lancet: Gastroenterology & Hepatology | Feb 06, 2019 GI Infectious Disease

Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease

Hepatology | Feb 05, 2019 GI Infectious Disease

« Prev 1 … 32 33 34 35 36 … 80 Next »

Efficacy of preoperative oral antibiotic prophylaxis for the prevention of surgical site infections in patients with Crohn disease: A randomized controlled trial

Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma

A retrospective study of the efficacy of sofosbuvir plus NS5A inhibitors for patients with hepatitis C virus genotype-2 chronic infection

Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: A collaboration of cohort studies

Sofosbuvir in combination with ribavirin or simeprevir: Real-life study of patients with hepatitis C genotype 4

Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection

Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM vs alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma

Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): An open-label, multicentre, single-arm, phase 3b trial

Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: A systematic review and pooled meta-analyses

Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Efficacy of preoperative oral antibiotic prophylaxis for the prevention of surgical site infections in patients with Crohn disease: A randomized controlled trial

Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma

A retrospective study of the efficacy of sofosbuvir plus NS5A inhibitors for patients with hepatitis C virus genotype-2 chronic infection

Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: A collaboration of cohort studies

Sofosbuvir in combination with ribavirin or simeprevir: Real-life study of patients with hepatitis C genotype 4

Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection

Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM vs alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma

Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): An open-label, multicentre, single-arm, phase 3b trial

Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: A systematic review and pooled meta-analyses

Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic